About
PolyMedics Innovations (PMI) is a research and development-driven company that focuses on innovative biomaterials and synthetic wound healing systems. Founded in 2001, PMI has established itself as a pioneer in synthetic skin technology, particularly with its flagship product, SUPRATHEL®. This synthetic, biodegradable skin substitute is designed for treating burn injuries and other wounds, and it has been used on over 250,000 patients worldwide. SUPRATHEL® has received CE approval in Europe and FDA clearance in the United States, making it available in over 40 countries. In addition to SUPRATHEL®, PMI offers SUPRA SDRM®, a biodegradable wound closure matrix for managing chronic and difficult-to-heal wounds. The company also distributes advanced wound care products from other manufacturers in key European markets. PMI collaborates with leading scientific centers and maintains a validated Quality Management System, holding ISO EN 13485 certification. With a significant presence in Europe and the U.S., PMI serves healthcare providers, hospitals, and clinics, aiming to enhance wound healing outcomes through its innovative solutions.
Technologies
Keywords
Company Information
-
Employees 60
-
Founded 2001
Location
1 Am Hegelesberg, Kirchheim unter Teck, Baden-Wuerttemberg, Germany, 73230
